ArticleScientific reports2026
Pituitary lesions in captive chimpanzees (Pan troglodytes): clinical presentation and histologic characterization.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pituitary lesions have been sporadically reported in captive chimpanzee (Pan troglodytes) populations. These lesions can be functional (hormone secreting) or non-functional. Functional lesions produce different clinical syndromes depending on the hormone produced. Previous reports of pituitary adenomas in chimpanzees have not characterized the tumors through clinical syndromes or by immunohistochemical features of the lesions. A retrospective review of necropsy and medical records from the Chimpanzee Care Center (CCC) at The University of Texas MD Anderson Cancer Center were queried to identify chimpanzees with a diagnosis of a pituitary lesion. These cases were evaluated using reticulin staining to distinguish between hyperplasia and neoplasia and an immunohistochemical panel for adrenocorticotrophic hormone, prolactin, growth hormone, and thyroid stimulating hormone to assess hormone expression. In accordance with recent changes by the World Health Organization that reclassified pituitary adenomas as pituitary neuroendocrine tumors (PitNETs), the lesions were diagnosed using the updated terminology. Ninety records were reviewed and 18 cases (20%) had pituitary lesions: 4 pituitary cysts, 5 hyperplastic lesions, and 9 PitNETs. The median age of the cases was 44 [Range: 27.5–54 years of age]. Most cases were in females (16/18; 88.9%). Clinical signs of galactorrhea and elevated prolactin levels (> 40 ng/mL) were reported in five animals diagnosed with plurihormonal hyperplasia (3/5), mammosomatotroph hyperplasia (1/5), and a lactrotroph PitNET (1/5), which indicates these lesions were functional. In the remaining cases, immunohistochemistry identified six ACTH + PitNETs, 1 plurihormonal PitNET, and 1 PitNET that was unclassifiable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.